Colorectal Cancer
Conditions
Interventions
Gold Standard:colonoscopy, Pathological examination
Detection 
Kit 
for 
Gene 
(Real 
PCR)(Product 
ColoSafe)
Sponsors
The Sixth Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
21 Years to 87 Years
Inclusion criteria
Inclusion criteria: 1. Patients with colorectal cancer; 2. Patients with suspected colorectal cancer; 3. Patients with digestive diseases such as guilt and polyps, and other cancer; 4. Healthy people; Inclusion criteria of supplementary clinical trial: 1. Interfering sample:Subject with other diseases or physiological conditions other than colorectal cancer, including but not limited to gastritis, gastric cancer, esophagitis, rheumatoid arthritis, prostate cancer, microbes (inflammation patients), gastrointestinal bleeding, drugs (typical digestive tract medication) Population), neuroendocrine cancer, squamous cell carcinoma (squamous squamous cell carcinoma, esophageal squamous cell carcinoma); 2. Follow-up sample subjects: Subjects who underwent resection of colorectal cancer lesions for at least 3 months in a prior clinical trial.
Exclusion criteria
Exclusion criteria: 1. Sample containing berberine; 2. Patients who discontinued the trial due to other systemic diseases during the trial; 3. Other patients who are considered unsuitable for this study (such as pregnancy, high blood pressure, heart disease, etc., who are not suitable for colonoscopy due to physical condition).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Specificity;ACC;Kappa; | — |
Countries
China
Contacts
Public ContactJianping Wang
The Sixth Affiliated Hospital, Sun Yat-sen University
Outcome results
None listed